- Home
- ALMS vs LTBR Comparison
ALMS vs LTBR Comparison
Compare ALMS & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMS
- LTBR
- Stock Information
- Founded
- ALMS 2021
- LTBR 1992
- Country
- ALMS United States
- LTBR United States
- Employees
- ALMS N/A
- LTBR N/A
- Industry
- ALMS
- LTBR Professional Services
- Sector
- ALMS
- LTBR Consumer Discretionary
- Exchange
- ALMS NYSE
- LTBR Nasdaq
- Market Cap
- ALMS 402.6M
- LTBR 326.6M
- IPO Year
- ALMS 2024
- LTBR N/A
- Fundamental
- Price
- ALMS $3.52
- LTBR $11.97
- Analyst Decision
- ALMS Strong Buy
- LTBR
- Analyst Count
- ALMS 7
- LTBR 0
- Target Price
- ALMS $24.50
- LTBR N/A
- AVG Volume (30 Days)
- ALMS 841.5K
- LTBR 1.6M
- Earning Date
- ALMS 08-12-2025
- LTBR 07-30-2025
- Dividend Yield
- ALMS N/A
- LTBR N/A
- EPS Growth
- ALMS N/A
- LTBR N/A
- EPS
- ALMS N/A
- LTBR N/A
- Revenue
- ALMS $17,389,000.00
- LTBR N/A
- Revenue This Year
- ALMS N/A
- LTBR N/A
- Revenue Next Year
- ALMS N/A
- LTBR N/A
- P/E Ratio
- ALMS N/A
- LTBR N/A
- Revenue Growth
- ALMS N/A
- LTBR N/A
- 52 Week Low
- ALMS $2.76
- LTBR $2.24
- 52 Week High
- ALMS $13.50
- LTBR $17.70
- Technical
- Relative Strength Index (RSI)
- ALMS N/A
- LTBR 42.87
- Support Level
- ALMS N/A
- LTBR $11.64
- Resistance Level
- ALMS N/A
- LTBR $13.29
- Average True Range (ATR)
- ALMS 0.00
- LTBR 0.91
- MACD
- ALMS 0.00
- LTBR -0.23
- Stochastic Oscillator
- ALMS 0.00
- LTBR 10.75
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.